Showing results (1601-1610 of 1,716) with videos related to
Sort By:
Pageof 172
Nature|June 24, 2021
Magnetic sensitivity of cryptochrome 4 from a migratory songbirdJingjing Xu, Lauren E Jarocha, Tilo Zollitsch, et al.European Heart Journal Open|October 16, 2023
Intima-media thickness at the near or far wall of the common carotid artery in cardiovascular risk assessmentLisa Seekircher, Lena Tschiderer, Lars Lind, et al.Journal of Veterinary Internal Medicine|March 23, 2020
Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC studyAdrian Boswood, Sonya G Gordon, Jens Häggström, et al.Intensive Care Medicine|November 18, 2017
Randomized, multicenter trial of lateral Trendelenburg versus semirecumbent body position for the prevention of ventilator-associated pneumoniaGianluigi Li Bassi, Mauro Panigada, Otavio T Ranzani, et al.Journal of Veterinary Internal Medicine|September 29, 2016
Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical TrialA Boswood, J Häggström, S G Gordon, et al.MMWR. Morbidity and Mortality Weekly Report|November 27, 2014
Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013Andrew F Auld, Simon G Agolory, Ray W Shiraishi, et al.BMC Research Notes|February 26, 2014
Association of academic performance of premedical students to satisfaction and engagement in a short training program: a cross sectional study presenting gender differencesJean Joel R Bigna, Loic Fonkoue, Manuela Francette F Tchatcho, et al.Journal of Veterinary Internal Medicine|December 8, 2017
Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC StudyA Boswood, S G Gordon, J Häggström, et al.Scientific Reports|December 8, 2023
Genomic surveillance of SARS-CoV-2 reveals highest severity and mortality of delta over other variants: evidence from CameroonJoseph Fokam, Rene Ghislain Essomba, Richard Njouom, et al.Virus Evolution|October 1, 2025
Tracking down the origin and subsequent spread of SARS-CoV-2 lineage B.1.619Nena Bollen, Samuel L Hong, Barney I Potter, et al.Pageof 172